Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ESR1
Z-value: 1.67
Motif logo
Transcription factors associated with ESR1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ESR1
|
ENSG00000091831.17 | estrogen receptor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ESR1 | hg19_v2_chr6_+_152128810_152128827 | 0.32 | 1.5e-06 | Click! |
Activity profile of ESR1 motif
Sorted Z-values of ESR1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_106209368 | 29.55 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr14_-_106054659 | 29.47 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr22_+_23248512 | 26.26 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr22_+_23165153 | 23.62 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr22_+_23247030 | 22.32 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr19_-_45826125 | 20.93 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
| chr22_+_23046750 | 19.92 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 (gene/pseudogene) |
| chr2_-_89513402 | 19.55 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
| chr22_+_23243156 | 18.76 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
| chr22_+_23241661 | 17.35 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr2_-_89310012 | 16.54 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr14_-_106642049 | 16.16 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr11_+_1891380 | 15.76 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
| chr19_+_49838653 | 15.10 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chr2_-_89292422 | 13.95 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr22_+_23077065 | 13.62 |
ENST00000390310.2
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr22_+_22930626 | 13.25 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr22_+_22681656 | 12.34 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr22_+_22936998 | 12.04 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
| chr19_+_42381173 | 11.66 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
| chr3_-_46506358 | 11.47 |
ENST00000417439.1
ENST00000431944.1 |
LTF
|
lactotransferrin |
| chr22_+_23029188 | 11.31 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr15_+_89181974 | 10.88 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr11_+_47270436 | 10.81 |
ENST00000395397.3
ENST00000405576.1 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
| chr15_+_89182178 | 10.78 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr12_+_112204691 | 10.30 |
ENST00000416293.3
ENST00000261733.2 |
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial) |
| chr11_+_47270475 | 10.28 |
ENST00000481889.2
ENST00000436778.1 ENST00000531660.1 ENST00000407404.1 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
| chr22_+_22676808 | 10.04 |
ENST00000390290.2
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr1_+_118148556 | 9.97 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
| chr9_+_139874683 | 9.70 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr22_+_23089870 | 9.61 |
ENST00000390311.2
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
| chr20_+_48429233 | 9.46 |
ENST00000417961.1
|
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 |
| chr20_+_48429356 | 9.07 |
ENST00000361573.2
ENST00000541138.1 ENST00000539601.1 |
SLC9A8
|
solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 |
| chr15_-_20170354 | 8.83 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
| chr16_+_1291240 | 8.74 |
ENST00000561736.1
|
TPSAB1
|
tryptase alpha/beta 1 |
| chr14_-_107078851 | 8.11 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr19_+_58790314 | 8.09 |
ENST00000196548.5
ENST00000608843.1 |
ZNF8
ZNF8
|
Zinc finger protein 8 zinc finger protein 8 |
| chr14_-_106453155 | 8.04 |
ENST00000390594.2
|
IGHV1-2
|
immunoglobulin heavy variable 1-2 |
| chr15_+_89182156 | 7.80 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
| chr14_-_106725723 | 7.65 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr17_-_34207295 | 7.64 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
| chr22_-_23922410 | 7.59 |
ENST00000249053.3
|
IGLL1
|
immunoglobulin lambda-like polypeptide 1 |
| chr19_-_13213662 | 7.48 |
ENST00000264824.4
|
LYL1
|
lymphoblastic leukemia derived sequence 1 |
| chrX_-_107019181 | 7.44 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr22_+_23154239 | 7.33 |
ENST00000390315.2
|
IGLV3-10
|
immunoglobulin lambda variable 3-10 |
| chr10_+_114135952 | 7.32 |
ENST00000356116.1
ENST00000433418.1 ENST00000354273.4 |
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr3_+_47021168 | 7.06 |
ENST00000450053.3
ENST00000292309.5 ENST00000383740.2 |
NBEAL2
|
neurobeachin-like 2 |
| chr13_-_46964177 | 6.75 |
ENST00000389908.3
|
KIAA0226L
|
KIAA0226-like |
| chr1_+_209848749 | 6.64 |
ENST00000367029.4
|
G0S2
|
G0/G1switch 2 |
| chr3_-_52488048 | 6.63 |
ENST00000232975.3
|
TNNC1
|
troponin C type 1 (slow) |
| chr7_+_149535455 | 6.48 |
ENST00000223210.4
ENST00000460379.1 |
ZNF862
|
zinc finger protein 862 |
| chr19_-_10445399 | 6.31 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr22_+_22735135 | 6.28 |
ENST00000390297.2
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
| chr2_-_220110111 | 6.27 |
ENST00000428427.1
ENST00000356283.3 ENST00000432839.1 ENST00000424620.1 |
GLB1L
|
galactosidase, beta 1-like |
| chr12_-_13256593 | 6.23 |
ENST00000542415.1
ENST00000324458.8 |
GSG1
|
germ cell associated 1 |
| chr20_+_3801162 | 6.20 |
ENST00000379573.2
ENST00000379567.2 ENST00000455742.1 ENST00000246041.2 |
AP5S1
|
adaptor-related protein complex 5, sigma 1 subunit |
| chr3_-_15469006 | 6.19 |
ENST00000443029.1
ENST00000383790.3 ENST00000383789.5 |
METTL6
|
methyltransferase like 6 |
| chr22_-_51016433 | 6.19 |
ENST00000405237.3
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle) |
| chr19_+_36024310 | 6.17 |
ENST00000222286.4
|
GAPDHS
|
glyceraldehyde-3-phosphate dehydrogenase, spermatogenic |
| chr10_+_88728189 | 6.12 |
ENST00000416348.1
|
ADIRF
|
adipogenesis regulatory factor |
| chr1_+_27561104 | 6.07 |
ENST00000361771.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
| chr2_+_30454390 | 5.91 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr4_+_190992087 | 5.88 |
ENST00000553598.1
|
DUX4L7
|
double homeobox 4 like 7 |
| chr22_-_51021397 | 5.87 |
ENST00000406938.2
|
CHKB
|
choline kinase beta |
| chr2_-_89247338 | 5.72 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
| chr12_-_14721283 | 5.71 |
ENST00000240617.5
|
PLBD1
|
phospholipase B domain containing 1 |
| chr22_-_24096630 | 5.59 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr19_-_42746714 | 5.58 |
ENST00000222330.3
|
GSK3A
|
glycogen synthase kinase 3 alpha |
| chr22_-_24096562 | 5.57 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
| chr11_-_47270341 | 5.53 |
ENST00000529444.1
ENST00000530453.1 ENST00000537863.1 ENST00000529788.1 ENST00000444355.2 ENST00000527256.1 ENST00000529663.1 ENST00000256997.3 |
ACP2
|
acid phosphatase 2, lysosomal |
| chr12_-_13256571 | 5.47 |
ENST00000545401.1
ENST00000432710.2 ENST00000351606.6 |
GSG1
|
germ cell associated 1 |
| chr11_-_64527425 | 5.46 |
ENST00000377432.3
|
PYGM
|
phosphorylase, glycogen, muscle |
| chr3_+_15468862 | 5.39 |
ENST00000396842.2
|
EAF1
|
ELL associated factor 1 |
| chr9_+_123970052 | 5.37 |
ENST00000373823.3
|
GSN
|
gelsolin |
| chr19_+_35759824 | 5.37 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
| chr16_-_28621312 | 5.35 |
ENST00000314752.7
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
| chr1_-_111970353 | 5.31 |
ENST00000369732.3
|
OVGP1
|
oviductal glycoprotein 1, 120kDa |
| chr19_+_7968728 | 5.30 |
ENST00000397981.3
ENST00000545011.1 ENST00000397983.3 ENST00000397979.3 |
MAP2K7
|
mitogen-activated protein kinase kinase 7 |
| chr21_+_40817749 | 5.29 |
ENST00000380637.3
ENST00000380634.1 ENST00000458295.1 ENST00000440288.2 ENST00000380631.1 |
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
| chr19_-_42498231 | 5.25 |
ENST00000602133.1
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chrX_-_106959631 | 5.24 |
ENST00000486554.1
ENST00000372390.4 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr5_-_1112141 | 5.23 |
ENST00000264930.5
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7 |
| chr22_+_39745930 | 5.17 |
ENST00000318801.4
ENST00000216155.7 ENST00000406293.3 ENST00000328933.5 |
SYNGR1
|
synaptogyrin 1 |
| chr19_+_56652686 | 5.16 |
ENST00000592949.1
|
ZNF444
|
zinc finger protein 444 |
| chr17_-_36348610 | 5.09 |
ENST00000339023.4
ENST00000354664.4 |
TBC1D3
|
TBC1 domain family, member 3 |
| chr19_-_42498369 | 4.96 |
ENST00000302102.5
ENST00000545399.1 |
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
| chr5_-_131347501 | 4.94 |
ENST00000543479.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
| chr14_+_106384295 | 4.86 |
ENST00000449410.1
ENST00000429431.1 |
KIAA0125
|
KIAA0125 |
| chr16_+_85061367 | 4.81 |
ENST00000538274.1
ENST00000258180.3 |
KIAA0513
|
KIAA0513 |
| chr11_+_43380459 | 4.79 |
ENST00000299240.6
ENST00000039989.4 |
TTC17
|
tetratricopeptide repeat domain 17 |
| chr17_-_34503867 | 4.74 |
ENST00000589443.1
ENST00000454519.3 ENST00000586369.1 |
TBC1D3B
|
TBC1 domain family, member 3B |
| chr17_-_34757039 | 4.73 |
ENST00000455054.2
ENST00000308078.7 |
TBC1D3H
TBC1D3C
|
TBC1 domain family, member 3H TBC1 domain family, member 3C |
| chr17_-_34808047 | 4.72 |
ENST00000592614.1
ENST00000591542.1 ENST00000330458.7 ENST00000341264.6 ENST00000592987.1 ENST00000400684.4 |
TBC1D3G
TBC1D3H
|
TBC1 domain family, member 3G TBC1 domain family, member 3H |
| chr22_+_39853258 | 4.71 |
ENST00000341184.6
|
MGAT3
|
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
| chr17_+_36283971 | 4.69 |
ENST00000327454.6
ENST00000378174.5 |
TBC1D3F
|
TBC1 domain family, member 3F |
| chrY_+_9365489 | 4.68 |
ENST00000428845.2
ENST00000444056.1 ENST00000429039.1 |
TSPY10
|
testis specific protein, Y-linked 10 |
| chr7_+_30068260 | 4.67 |
ENST00000440706.2
|
PLEKHA8
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 |
| chr22_-_23922448 | 4.66 |
ENST00000438703.1
ENST00000330377.2 |
IGLL1
|
immunoglobulin lambda-like polypeptide 1 |
| chrY_+_9175073 | 4.63 |
ENST00000426950.2
ENST00000383008.1 |
TSPY4
|
testis specific protein, Y-linked 4 |
| chr5_-_42825983 | 4.63 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
| chr8_+_103563792 | 4.63 |
ENST00000285402.3
|
ODF1
|
outer dense fiber of sperm tails 1 |
| chr17_-_27507395 | 4.59 |
ENST00000354329.4
ENST00000527372.1 |
MYO18A
|
myosin XVIIIA |
| chr17_-_27507377 | 4.59 |
ENST00000531253.1
|
MYO18A
|
myosin XVIIIA |
| chrY_+_9324922 | 4.55 |
ENST00000440215.2
ENST00000446779.2 |
TSPY6P
|
testis specific protein, Y-linked 6, pseudogene |
| chr4_+_668348 | 4.50 |
ENST00000511290.1
|
MYL5
|
myosin, light chain 5, regulatory |
| chr19_+_8478154 | 4.49 |
ENST00000381035.4
ENST00000595142.1 ENST00000601724.1 ENST00000393944.1 ENST00000215555.2 ENST00000601283.1 ENST00000595213.1 |
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
| chr11_-_1036706 | 4.48 |
ENST00000421673.2
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming |
| chr12_+_52301175 | 4.46 |
ENST00000388922.4
|
ACVRL1
|
activin A receptor type II-like 1 |
| chr2_+_231090433 | 4.39 |
ENST00000486687.2
ENST00000350136.5 ENST00000392045.3 ENST00000417495.3 ENST00000343805.6 ENST00000420434.3 |
SP140
|
SP140 nuclear body protein |
| chr19_+_2389784 | 4.36 |
ENST00000332578.3
|
TMPRSS9
|
transmembrane protease, serine 9 |
| chr19_-_51512804 | 4.35 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
| chr11_-_59383617 | 4.35 |
ENST00000263847.1
|
OSBP
|
oxysterol binding protein |
| chr2_+_233925064 | 4.33 |
ENST00000359570.5
ENST00000538935.1 |
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa |
| chr17_-_34592032 | 4.31 |
ENST00000457979.3
|
TBC1D3C
|
TBC1 domain family, member 3C |
| chr6_-_136871957 | 4.28 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
| chr1_+_9711781 | 4.24 |
ENST00000536656.1
ENST00000377346.4 |
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
| chr9_-_35619539 | 4.24 |
ENST00000396757.1
|
CD72
|
CD72 molecule |
| chrY_+_9195406 | 4.17 |
ENST00000287721.9
ENST00000383005.2 ENST00000383000.1 ENST00000330628.9 ENST00000537415.1 |
TSPY8
|
testis specific protein, Y-linked 8 |
| chr19_-_54784353 | 4.11 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
| chr16_-_55866997 | 4.06 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chr6_-_2903514 | 4.00 |
ENST00000380698.4
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
| chr6_-_49712147 | 3.96 |
ENST00000433368.2
ENST00000354620.4 |
CRISP3
|
cysteine-rich secretory protein 3 |
| chr9_-_33264557 | 3.91 |
ENST00000473781.1
ENST00000488499.1 |
BAG1
|
BCL2-associated athanogene |
| chr14_+_75536280 | 3.90 |
ENST00000238686.8
|
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
| chr20_+_61584026 | 3.88 |
ENST00000370351.4
ENST00000370349.3 |
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
| chr2_+_11679963 | 3.87 |
ENST00000263834.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
| chr1_+_245133278 | 3.85 |
ENST00000366522.2
|
EFCAB2
|
EF-hand calcium binding domain 2 |
| chr2_-_160761179 | 3.77 |
ENST00000554112.1
ENST00000553424.1 ENST00000263636.4 ENST00000504764.1 ENST00000505052.1 |
LY75
LY75-CD302
|
lymphocyte antigen 75 LY75-CD302 readthrough |
| chr8_+_11141925 | 3.76 |
ENST00000221086.3
|
MTMR9
|
myotubularin related protein 9 |
| chr6_-_41703296 | 3.75 |
ENST00000373033.1
|
TFEB
|
transcription factor EB |
| chr7_-_99569468 | 3.75 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr14_+_94577074 | 3.75 |
ENST00000444961.1
ENST00000448882.1 ENST00000557098.1 ENST00000554800.1 ENST00000556544.1 ENST00000298902.5 ENST00000555819.1 ENST00000557634.1 ENST00000555744.1 |
IFI27
|
interferon, alpha-inducible protein 27 |
| chr16_+_29471210 | 3.74 |
ENST00000360423.7
|
SULT1A4
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 |
| chr5_+_134240588 | 3.72 |
ENST00000254908.6
|
PCBD2
|
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 |
| chr17_-_79869340 | 3.72 |
ENST00000538936.2
|
PCYT2
|
phosphate cytidylyltransferase 2, ethanolamine |
| chr17_-_39677971 | 3.71 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
| chr6_-_91006461 | 3.70 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
| chr11_-_615570 | 3.70 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
| chr16_+_1383602 | 3.68 |
ENST00000426824.3
ENST00000397488.2 ENST00000562208.1 ENST00000568887.1 |
BAIAP3
|
BAI1-associated protein 3 |
| chr8_+_11351876 | 3.62 |
ENST00000529894.1
|
BLK
|
B lymphoid tyrosine kinase |
| chr20_-_62258394 | 3.61 |
ENST00000370077.1
|
GMEB2
|
glucocorticoid modulatory element binding protein 2 |
| chr5_-_693500 | 3.56 |
ENST00000360578.5
|
TPPP
|
tubulin polymerization promoting protein |
| chr9_+_100174344 | 3.55 |
ENST00000422139.2
|
TDRD7
|
tudor domain containing 7 |
| chr11_-_61684962 | 3.52 |
ENST00000394836.2
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
| chr12_-_124457371 | 3.46 |
ENST00000238156.3
ENST00000545037.1 |
CCDC92
|
coiled-coil domain containing 92 |
| chr19_-_11639931 | 3.42 |
ENST00000592312.1
ENST00000590480.1 ENST00000585318.1 ENST00000252440.7 ENST00000417981.2 ENST00000270517.7 |
ECSIT
|
ECSIT signalling integrator |
| chr16_+_19729586 | 3.42 |
ENST00000564186.1
ENST00000541926.1 ENST00000433597.2 |
IQCK
|
IQ motif containing K |
| chr14_+_75536335 | 3.41 |
ENST00000554763.1
ENST00000439583.2 ENST00000526130.1 ENST00000525046.1 |
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
| chr3_-_13461807 | 3.37 |
ENST00000254508.5
|
NUP210
|
nucleoporin 210kDa |
| chr8_+_120885949 | 3.35 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chrX_+_77166172 | 3.34 |
ENST00000343533.5
ENST00000350425.4 ENST00000341514.6 |
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide |
| chr1_+_76262552 | 3.32 |
ENST00000263187.3
|
MSH4
|
mutS homolog 4 |
| chr16_+_1290725 | 3.30 |
ENST00000461509.2
|
TPSAB1
|
tryptase alpha/beta 1 |
| chr1_-_236445251 | 3.28 |
ENST00000354619.5
ENST00000327333.8 |
ERO1LB
|
ERO1-like beta (S. cerevisiae) |
| chr14_-_106471723 | 3.27 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
| chr10_+_131265443 | 3.27 |
ENST00000306010.7
|
MGMT
|
O-6-methylguanine-DNA methyltransferase |
| chr5_-_131347583 | 3.27 |
ENST00000379255.1
ENST00000430403.1 ENST00000544770.1 ENST00000379246.1 ENST00000414078.1 ENST00000441995.1 |
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
| chr16_+_30210552 | 3.22 |
ENST00000338971.5
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
| chr8_+_11351494 | 3.21 |
ENST00000259089.4
|
BLK
|
B lymphoid tyrosine kinase |
| chr4_+_190992387 | 3.18 |
ENST00000554906.2
ENST00000553820.2 |
DUX4L7
|
double homeobox 4 like 7 |
| chr14_+_103995546 | 3.16 |
ENST00000299202.4
|
TRMT61A
|
tRNA methyltransferase 61 homolog A (S. cerevisiae) |
| chr8_-_41522779 | 3.16 |
ENST00000522231.1
ENST00000314214.8 ENST00000348036.4 ENST00000457297.1 ENST00000522543.1 |
ANK1
|
ankyrin 1, erythrocytic |
| chr11_-_6677018 | 3.16 |
ENST00000299441.3
|
DCHS1
|
dachsous cadherin-related 1 |
| chr6_+_35265586 | 3.15 |
ENST00000542066.1
ENST00000316637.5 |
DEF6
|
differentially expressed in FDCP 6 homolog (mouse) |
| chr14_-_21492113 | 3.14 |
ENST00000554094.1
|
NDRG2
|
NDRG family member 2 |
| chr5_+_110559784 | 3.14 |
ENST00000282356.4
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV |
| chr5_-_132202329 | 3.11 |
ENST00000378673.2
|
GDF9
|
growth differentiation factor 9 |
| chr16_+_66914264 | 3.11 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
| chr11_+_14665373 | 3.10 |
ENST00000455098.2
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
| chr9_-_139096955 | 3.10 |
ENST00000371748.5
|
LHX3
|
LIM homeobox 3 |
| chr3_+_93781728 | 3.06 |
ENST00000314622.4
|
NSUN3
|
NOP2/Sun domain family, member 3 |
| chr16_+_89686991 | 3.06 |
ENST00000393092.3
|
DPEP1
|
dipeptidase 1 (renal) |
| chr2_-_242041607 | 3.04 |
ENST00000434791.1
ENST00000401626.2 ENST00000439144.1 ENST00000406593.1 ENST00000495694.1 ENST00000407095.3 ENST00000391980.2 |
MTERFD2
|
MTERF domain containing 2 |
| chr1_-_59043166 | 3.04 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
| chr22_+_22550113 | 3.03 |
ENST00000390285.3
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr12_-_124457257 | 3.03 |
ENST00000545891.1
|
CCDC92
|
coiled-coil domain containing 92 |
| chr16_-_28621298 | 3.01 |
ENST00000566189.1
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 |
| chr4_-_89080003 | 2.96 |
ENST00000237612.3
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 |
| chr16_-_21289627 | 2.96 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
| chr22_-_19137796 | 2.95 |
ENST00000086933.2
|
GSC2
|
goosecoid homeobox 2 |
| chr15_+_42696992 | 2.94 |
ENST00000561817.1
|
CAPN3
|
calpain 3, (p94) |
| chr1_-_24151903 | 2.93 |
ENST00000436439.2
ENST00000374490.3 |
HMGCL
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase |
| chr3_-_122512619 | 2.93 |
ENST00000383659.1
ENST00000306103.2 |
HSPBAP1
|
HSPB (heat shock 27kDa) associated protein 1 |
| chr3_-_15106747 | 2.92 |
ENST00000449354.2
ENST00000444840.2 ENST00000253686.2 |
MRPS25
|
mitochondrial ribosomal protein S25 |
| chr5_+_149109825 | 2.92 |
ENST00000360453.4
ENST00000394320.3 ENST00000309241.5 |
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta |
| chr16_+_20420849 | 2.91 |
ENST00000575584.1
ENST00000331849.4 |
ACSM5
|
acyl-CoA synthetase medium-chain family member 5 |
| chr4_-_860950 | 2.91 |
ENST00000511980.1
ENST00000510799.1 |
GAK
|
cyclin G associated kinase |
| chr12_+_57914742 | 2.90 |
ENST00000551351.1
|
MBD6
|
methyl-CpG binding domain protein 6 |
| chr19_-_11639910 | 2.89 |
ENST00000588998.1
ENST00000586149.1 |
ECSIT
|
ECSIT signalling integrator |
| chr3_+_121554046 | 2.88 |
ENST00000273668.2
ENST00000451944.2 |
EAF2
|
ELL associated factor 2 |
| chr14_-_21492251 | 2.85 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
| chr6_+_24495067 | 2.85 |
ENST00000357578.3
ENST00000546278.1 ENST00000491546.1 |
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1 |
| chr1_+_55107449 | 2.84 |
ENST00000421030.2
ENST00000545244.1 ENST00000339553.5 ENST00000409996.1 ENST00000454855.2 |
MROH7
|
maestro heat-like repeat family member 7 |
| chr17_-_19771216 | 2.82 |
ENST00000395544.4
|
ULK2
|
unc-51 like autophagy activating kinase 2 |
| chr15_+_42697018 | 2.81 |
ENST00000397204.4
|
CAPN3
|
calpain 3, (p94) |
| chr6_+_32121218 | 2.78 |
ENST00000414204.1
ENST00000361568.2 ENST00000395523.1 |
PPT2
|
palmitoyl-protein thioesterase 2 |
| chr6_-_159420780 | 2.77 |
ENST00000449822.1
|
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
| chr11_+_17756279 | 2.77 |
ENST00000265969.6
|
KCNC1
|
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
| chr5_-_154230130 | 2.75 |
ENST00000519501.1
ENST00000518651.1 ENST00000517938.1 ENST00000520461.1 |
FAXDC2
|
fatty acid hydroxylase domain containing 2 |
| chr14_+_103995503 | 2.73 |
ENST00000389749.4
|
TRMT61A
|
tRNA methyltransferase 61 homolog A (S. cerevisiae) |
Network of associatons between targets according to the STRING database.
First level regulatory network of ESR1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.8 | 29.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 7.0 | 21.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 3.8 | 11.5 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 3.1 | 9.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 2.9 | 29.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 2.0 | 15.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.9 | 7.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.9 | 20.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.9 | 5.6 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
| 1.8 | 5.3 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 1.7 | 6.6 | GO:0032972 | diaphragm contraction(GO:0002086) regulation of muscle filament sliding speed(GO:0032972) |
| 1.6 | 12.7 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.6 | 4.7 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 1.4 | 4.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.3 | 5.4 | GO:0019086 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) late viral transcription(GO:0019086) |
| 1.3 | 4.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 1.3 | 10.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 1.2 | 85.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.2 | 11.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 1.2 | 5.9 | GO:2000035 | positive regulation of somatic stem cell population maintenance(GO:1904674) regulation of stem cell division(GO:2000035) |
| 1.2 | 18.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 1.1 | 3.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 1.1 | 6.8 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 1.1 | 3.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 1.1 | 5.4 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 1.1 | 3.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 1.0 | 3.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 1.0 | 10.3 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 1.0 | 6.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 1.0 | 3.1 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 1.0 | 3.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) cellular amide catabolic process(GO:0043605) |
| 1.0 | 2.9 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 1.0 | 3.8 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.9 | 2.7 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.9 | 7.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.9 | 3.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.9 | 2.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 0.9 | 1.7 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.9 | 3.5 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.8 | 4.2 | GO:0060374 | positive regulation of neutrophil apoptotic process(GO:0033031) mast cell differentiation(GO:0060374) |
| 0.8 | 2.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.8 | 2.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.8 | 1.6 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
| 0.8 | 3.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.8 | 4.7 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.8 | 138.9 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.8 | 6.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.8 | 2.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.8 | 18.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.8 | 3.0 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.7 | 3.7 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.7 | 2.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.7 | 4.9 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 | 2.1 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.7 | 2.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.7 | 1.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.7 | 64.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.7 | 2.0 | GO:0032641 | negative regulation of tolerance induction(GO:0002644) lymphotoxin A production(GO:0032641) interleukin-4 biosynthetic process(GO:0042097) lymphotoxin A biosynthetic process(GO:0042109) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.7 | 2.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.6 | 5.5 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.6 | 1.8 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.6 | 3.0 | GO:0007507 | heart development(GO:0007507) |
| 0.6 | 2.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.6 | 4.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.6 | 1.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.6 | 1.1 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.6 | 2.8 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.6 | 3.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.5 | 3.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.5 | 10.9 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol catabolic process(GO:0006068) |
| 0.5 | 11.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.5 | 9.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.5 | 1.6 | GO:1904300 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.5 | 2.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.5 | 2.1 | GO:0001757 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
| 0.5 | 2.6 | GO:1901093 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.5 | 1.5 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.5 | 3.1 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.5 | 1.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 | 1.5 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.5 | 1.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.5 | 1.9 | GO:0097676 | regulation of mRNA export from nucleus(GO:0010793) cell migration involved in vasculogenesis(GO:0035441) histone H3-K36 dimethylation(GO:0097676) |
| 0.5 | 1.4 | GO:0090155 | glucosylceramide biosynthetic process(GO:0006679) negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.5 | 3.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
| 0.5 | 0.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 | 1.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.5 | 7.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.5 | 1.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.4 | 2.2 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.4 | 1.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 1.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 | 5.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 | 2.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.4 | 3.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.4 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.4 | 1.6 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.4 | 4.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 0.4 | 6.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 | 4.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
| 0.4 | 1.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 | 2.3 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.4 | 1.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 | 3.3 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.4 | 3.3 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.4 | 2.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.4 | 3.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.4 | 1.8 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.3 | 2.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 2.1 | GO:0010193 | response to ozone(GO:0010193) |
| 0.3 | 6.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.3 | 1.7 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.3 | 27.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.3 | 3.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 2.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.3 | 1.3 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.3 | 3.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.3 | 8.0 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.3 | 2.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.3 | 3.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.3 | 3.0 | GO:0015886 | heme transport(GO:0015886) |
| 0.3 | 2.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 2.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.3 | 2.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 | 18.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.3 | 7.1 | GO:0030220 | platelet formation(GO:0030220) |
| 0.3 | 1.7 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.3 | 3.0 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.3 | 6.4 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.3 | 0.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 | 0.8 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.3 | 2.1 | GO:0060501 | negative regulation of keratinocyte differentiation(GO:0045617) positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.3 | 1.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.3 | 0.8 | GO:0043366 | beta selection(GO:0043366) |
| 0.3 | 1.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 6.2 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.3 | 1.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.3 | 2.5 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.2 | 2.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.2 | 6.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.2 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 2.2 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.2 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 0.7 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 | 1.4 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 1.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.2 | 2.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.2 | 1.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 | 1.4 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.2 | 1.6 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 | 0.6 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 0.2 | 1.7 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.2 | 1.3 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 | 6.8 | GO:0060384 | innervation(GO:0060384) |
| 0.2 | 5.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 13.4 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.2 | 2.4 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.2 | 3.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.2 | 2.0 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 | 2.3 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 | 0.5 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.2 | 2.7 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.2 | 1.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.2 | 1.4 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 0.7 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.2 | 1.2 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.2 | 5.5 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 2.3 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.2 | 2.4 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 1.7 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.8 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.2 | 42.8 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.2 | 1.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 2.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 1.8 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.1 | 1.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.6 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
| 0.1 | 3.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 3.7 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 1.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 | 0.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 1.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 0.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 | 1.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.1 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.1 | 0.6 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 1.9 | GO:0050900 | leukocyte migration(GO:0050900) |
| 0.1 | 2.0 | GO:0030575 | nuclear body organization(GO:0030575) |
| 0.1 | 0.5 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.9 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 2.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 1.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 | 1.1 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.1 | 6.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.7 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.1 | 2.5 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
| 0.1 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.1 | 0.4 | GO:0070942 | cytolysis in other organism involved in symbiotic interaction(GO:0051801) neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.1 | 1.7 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 | 1.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 | 2.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.1 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 | 3.8 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.1 | 2.4 | GO:0007616 | long-term memory(GO:0007616) |
| 0.1 | 1.7 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 2.8 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 1.8 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 0.6 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 0.1 | 2.4 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 1.5 | GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling(GO:1905114) |
| 0.1 | 0.8 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 0.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 | 1.7 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 1.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 | 5.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 1.9 | GO:0016032 | viral process(GO:0016032) multi-organism cellular process(GO:0044764) |
| 0.1 | 0.9 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 1.7 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.1 | 1.8 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
| 0.1 | 1.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 1.3 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 0.1 | 3.7 | GO:0006584 | catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.1 | 1.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 1.9 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 2.9 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
| 0.1 | 6.4 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.1 | 0.6 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.1 | 0.9 | GO:2000278 | regulation of DNA biosynthetic process(GO:2000278) |
| 0.1 | 2.6 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 1.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 3.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 1.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 4.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.1 | 2.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.8 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.1 | 1.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 1.9 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 1.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 0.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.1 | 2.7 | GO:0099531 | neurotransmitter secretion(GO:0007269) presynaptic process involved in chemical synaptic transmission(GO:0099531) signal release from synapse(GO:0099643) |
| 0.0 | 0.3 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 | 0.6 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 5.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 2.5 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
| 0.0 | 0.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.0 | 1.5 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.0 | 4.8 | GO:0044782 | cilium organization(GO:0044782) |
| 0.0 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.5 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 7.0 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.0 | 2.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 1.5 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.0 | 3.0 | GO:0007286 | spermatid development(GO:0007286) |
| 0.0 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 1.7 | GO:0050776 | regulation of immune response(GO:0050776) |
| 0.0 | 0.2 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.0 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.0 | 1.0 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.0 | 3.1 | GO:0070268 | cornification(GO:0070268) |
| 0.0 | 0.6 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 2.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 | 2.7 | GO:0045087 | innate immune response(GO:0045087) |
| 0.0 | 2.8 | GO:0006006 | glucose metabolic process(GO:0006006) |
| 0.0 | 1.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.0 | 0.6 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
| 0.0 | 0.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.0 | 0.9 | GO:0007605 | sensory perception of sound(GO:0007605) |
| 0.0 | 0.1 | GO:0031960 | response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.0 | 0.9 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.1 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.0 | 1.1 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.8 | 29.5 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 2.1 | 2.1 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 2.0 | 5.9 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 1.8 | 85.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.7 | 11.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 1.6 | 11.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 1.3 | 6.4 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 1.1 | 6.6 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 1.1 | 3.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.9 | 10.2 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.8 | 3.3 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.8 | 1.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.7 | 4.6 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.7 | 1.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.6 | 1.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.6 | 6.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.5 | 1.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.5 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
| 0.5 | 4.7 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.5 | 31.9 | GO:0015030 | Cajal body(GO:0015030) |
| 0.5 | 5.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.4 | 1.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.4 | 1.5 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.4 | 2.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.4 | 5.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.4 | 9.5 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.4 | 5.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.4 | 1.8 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.4 | 2.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.3 | 56.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 2.5 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.3 | 1.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 2.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 2.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 3.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 0.7 | GO:0098536 | deuterosome(GO:0098536) |
| 0.2 | 2.1 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 0.7 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 2.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.2 | 2.3 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 6.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 13.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 3.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 1.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.2 | 2.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.2 | 3.0 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.2 | 2.4 | GO:0010369 | chromocenter(GO:0010369) |
| 0.2 | 2.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 3.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 2.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.2 | 14.9 | GO:0016459 | myosin complex(GO:0016459) |
| 0.2 | 1.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 5.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 3.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 1.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 3.9 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 3.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 8.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.1 | 2.7 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 4.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 167.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 2.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 1.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 2.8 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 2.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.1 | 1.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.1 | 6.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 8.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 2.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 18.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 2.9 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 0.5 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.1 | 1.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 8.3 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 1.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 0.8 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.1 | 4.0 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 6.2 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.6 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 1.0 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 1.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 1.9 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 1.6 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 2.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 5.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 6.6 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 1.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 8.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.3 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.0 | 0.3 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.0 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.0 | 0.2 | GO:0097433 | dense body(GO:0097433) |
| 0.0 | 6.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 1.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 1.7 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 2.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 1.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
| 0.0 | 1.9 | GO:0098858 | actin-based cell projection(GO:0098858) |
| 0.0 | 1.7 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) |
| 0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 1.7 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 10.5 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 4.8 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 5.2 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.8 | 29.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 5.3 | 21.1 | GO:0032810 | sterol response element binding(GO:0032810) |
| 2.6 | 20.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 2.4 | 9.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 2.1 | 115.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 2.0 | 5.9 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 2.0 | 5.9 | GO:0004103 | choline kinase activity(GO:0004103) |
| 1.9 | 18.5 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 1.8 | 5.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.5 | 6.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 1.4 | 4.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.4 | 10.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 1.4 | 12.7 | GO:0043426 | MRF binding(GO:0043426) |
| 1.4 | 5.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 1.2 | 6.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 1.2 | 4.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) ceramide binding(GO:0097001) |
| 1.1 | 3.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 1.1 | 4.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.1 | 3.3 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 1.1 | 7.6 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.0 | 3.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.0 | 4.1 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 1.0 | 17.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 1.0 | 179.4 | GO:0003823 | antigen binding(GO:0003823) |
| 0.9 | 3.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.9 | 7.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.9 | 3.6 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.8 | 1.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.8 | 4.1 | GO:0004771 | sterol esterase activity(GO:0004771) methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.8 | 6.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.8 | 9.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.7 | 3.7 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.7 | 3.0 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.7 | 7.9 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.7 | 2.0 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.6 | 7.0 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.6 | 4.3 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.6 | 1.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.6 | 3.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.6 | 4.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.6 | 7.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.6 | 1.8 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.6 | 1.7 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.6 | 4.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.5 | 3.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.5 | 2.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.5 | 3.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 1.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.5 | 1.5 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.5 | 6.8 | GO:0031432 | titin binding(GO:0031432) |
| 0.5 | 5.3 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.5 | 1.4 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.5 | 1.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.5 | 5.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.5 | 2.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.4 | 1.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.4 | 3.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.4 | 2.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.4 | 3.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.4 | 13.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.4 | 7.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.4 | 1.5 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
| 0.4 | 2.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.4 | 1.5 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.4 | 1.9 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 1.5 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.4 | 1.9 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 3.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.4 | 3.7 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.4 | 3.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.4 | 2.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.4 | 1.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.4 | 3.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.4 | 1.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.4 | 2.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.3 | 2.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 1.4 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.3 | 3.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.3 | 3.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 2.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.3 | 2.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.3 | 6.8 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.3 | 1.6 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.3 | 5.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.3 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.3 | 1.5 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.3 | 3.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.3 | 2.3 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 3.5 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.3 | 5.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.3 | 0.8 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.3 | 1.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.3 | 0.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 3.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 1.0 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.2 | 3.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.2 | 2.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 6.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 2.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.2 | 1.0 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.2 | 6.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 1.2 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.2 | 2.7 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 2.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.2 | 1.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.2 | 3.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.2 | 0.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.2 | 0.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.2 | 0.6 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 0.2 | 2.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 0.2 | 1.2 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.2 | 1.3 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 2.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 0.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.2 | 0.7 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 3.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.2 | 1.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 2.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.2 | 1.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 0.7 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 1.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.2 | 2.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.2 | 4.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 3.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.2 | 2.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
| 0.2 | 4.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 0.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.2 | 2.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 1.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.2 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.1 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.6 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.1 | 32.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 3.9 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 6.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 2.8 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 1.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 1.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 22.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.1 | 0.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.1 | 5.9 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 7.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
| 0.1 | 9.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 7.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 0.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 1.5 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.1 | 1.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 0.5 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 5.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 1.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 2.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.1 | 2.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.1 | 1.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.1 | 3.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
| 0.1 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 1.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 2.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 3.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 1.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
| 0.1 | 0.3 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 3.0 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.1 | 2.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 2.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 2.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.1 | 1.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.1 | 0.7 | GO:0022841 | outward rectifier potassium channel activity(GO:0015271) potassium ion leak channel activity(GO:0022841) |
| 0.1 | 1.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 1.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 3.2 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 3.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 1.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 4.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.1 | 1.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.1 | 2.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 2.0 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 1.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 1.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 4.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.0 | 1.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.6 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.0 | 3.3 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.0 | 1.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 1.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 1.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.0 | 1.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 2.7 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 2.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.0 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 1.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 5.0 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 2.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.0 | 0.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 1.5 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 0.0 | 0.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 1.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 2.5 | GO:0003729 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.7 | GO:0005518 | collagen binding(GO:0005518) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 3.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.4 | 9.8 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.4 | 19.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.4 | 9.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.3 | 34.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.3 | 14.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 4.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.3 | 6.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 20.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.2 | 3.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 5.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.2 | 3.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.2 | 7.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.2 | 1.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 5.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 1.7 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 8.3 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 1.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 2.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 4.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 6.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 4.5 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 4.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 5.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 1.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 2.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 2.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 2.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 5.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 5.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 2.9 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.1 | 1.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 3.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 3.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 3.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 3.0 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 3.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 3.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 11.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 3.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 4.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 15.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.0 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.0 | 3.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.9 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 1.5 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.0 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 10.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.9 | 18.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.7 | 1.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.6 | 11.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.5 | 27.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.4 | 11.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.4 | 35.8 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.3 | 6.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.3 | 12.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 0.9 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.3 | 5.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.3 | 1.5 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.3 | 5.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 1.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.3 | 3.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.3 | 5.5 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.3 | 14.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 7.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 3.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 6.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 3.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 6.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.2 | 26.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.2 | 2.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 3.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 16.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 3.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 3.3 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.2 | 2.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 2.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.2 | 14.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.2 | 4.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.2 | 1.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 4.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 4.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 4.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 6.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.1 | 7.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.1 | 4.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 2.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 2.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 7.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 3.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.1 | 2.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 4.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 4.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.1 | 2.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 8.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 2.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.1 | 2.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.1 | 1.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 1.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 5.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 4.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 1.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 4.5 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.1 | 1.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 3.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.1 | 0.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 1.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 2.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 8.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.0 | 1.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 1.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.6 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 1.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.0 | 5.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.0 | 1.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 1.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.0 | 2.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.0 | 0.8 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 3.0 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 1.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |